Novogenia AG (MUN: 7V0)
Health Care · Biotechnology · DE
€6.00
+0.84% today · -4.0% 1Y
Novogenia AG (MUN: 7V0) operates in the Biotechnology industry within the Health Care sector. The company is valued at $83.08M.
Over the last twelve months the share price has lost 4.0%, trading between 5.70 and 11.80.
Tweenvest scores Novogenia AG across four factors: quality 52/100, value 70/100, dividend 90/100. Its strongest factor is dividend.
7V0 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $83.08M
- Revenue (TTM)
- $63.76M
- P/E
- 132.00
- EPS
- 0.05
- Dividend yield
- 9.38%
- Beta (5Y)
- 0.31
- 52-week high
- €11.80
- 52-week low
- €5.70
- Avg volume (3M)
- —
- Shares outstanding
- 12.00M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.